LabCorp is Scheduled to Present at the 28th Annual J.P. Morgan Healthcare Conference

BURLINGTON, N.C., Jan 05, 2010 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH) today announced that David P. King, Chairman and Chief Executive Officer, is scheduled to speak at the 28th Annual J.P. Morgan Healthcare Conference in San Francisco, CA.

LabCorp Receives Notification from the Holders of the Minority Interest in the Company's Ontario, Canada Joint Venture

BURLINGTON, N.C., Dec 15, 2009 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announced today that it has received notification from the holders of the minority interest in the Company's Ontario, Canada joint venture, that they intend to put their remaining

LabCorp is Scheduled to Attend Deutsche Bank's 3rd Annual MedTools Investor Summit

BURLINGTON, N.C. --(BUSINESS WIRE)--Dec. 3, 2009-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE:LH) today announced that David P. King , Chairman and Chief Executive Officer, is scheduled to attend Deutsche Bank’s 3rd Annual MedTools Investor Summit in Boston, MA.

LabCorp is Scheduled to Present at the 21st Annual Piper Jaffray Health Care Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Nov. 23, 2009-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced that David P. King , Chairman and Chief Executive Officer, is scheduled to speak at the 21 st Annual Piper Jaffray Health Care Conference in New York City , NY.

LabCorp is Scheduled to Present at the Credit Suisse 18th Annual Healthcare Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Nov. 6, 2009-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced that William B. (Brad) Hayes , Executive Vice President and Chief Financial Officer, is scheduled to speak at the Credit Suisse 18 th Annual Healthcare Conference

Laboratory Corporation of America(R) Holdings Announces 2009 Third Quarter Results

Revenue Growth and Margin Expansion Drive Adjusted EPS of $1.22 and Operating Cash Flow of $246.4 Million BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 22, 2009-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced results for the quarter ended September 30, 2009 .

LabCorp is Scheduled to Present at the UBS 2009 Global Life Sciences Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 11, 2009-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE:LH) today announced that David P. King , Chairman and Chief Executive Officer, is scheduled to speak at the UBS 2009 Global Life Sciences Conference in New York City , NY.

LabCorp is Scheduled to Present at the Bank of America Merrill Lynch Global Healthcare Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 8, 2009-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced that David P. King , Chairman and Chief Executive Officer, is scheduled to speak at the Bank of America Merrill Lynch Global Healthcare Conference in London,

LabCorp Announces $250 Million Stock Repurchase Program

BURLINGTON, N.C., Aug 10, 2009 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (NYSE: LH) today announced that its Board of Directors has authorized a new stock repurchase program under which LabCorp may purchase up to an aggregate of $250 million of its Common Stock from

LabCorp Successfully Completes Acquisition of Monogram Biosciences, Inc.

BURLINGTON, N.C. --(BUSINESS WIRE)--Aug. 4, 2009-- Laboratory Corporation of America® Holdings (NYSE:LH) today announced the successful completion of its acquisition of Monogram Biosciences, Inc. LabCorp acquired Monogram pursuant to a cash tender offer followed by the merger of a wholly-owned